Datasets:
avi10
/
raw-dataset-T1

Dataset card Data Studio Files
xet
 Community
2
id
stringlengths
11
11
tags
stringlengths
10
513
text
stringlengths
3
1.35k
entities
dict
ner_tags
listlengths
1
222
tokens
listlengths
1
222
__index_level_0__
int64
0
7.36k
NCT02504866
30:33:chronic_disease
Diagnosis of non-penetrating TBI
{ "allergy_name": null, "cancer": null, "chronic_disease": "TBI", "treatment": null }
[ 0, 0, 0, 2 ]
[ "Diagnosis", "of", "non-penetrating", "TBI" ]
2,002
NCT02469857
1:32:chronic_disease,,
Chronic neurological impairment that leads to a neuro mSOFA component ≥2
{ "allergy_name": null, "cancer": null, "chronic_disease": "Chronic neurological impairment", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Chronic", "neurological", "impairment", "that", "leads", "to", "a", "neuro", "mSOFA", "component", "≥2" ]
4,368
NCT00632853
1:13:treatment
chemotherapy
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "chemotherapy" }
[ 1 ]
[ "chemotherapy" ]
392
NCT03088033
25:38:chronic_disease
Presence of significant valve disease defined by the site cardiologist
{ "allergy_name": null, "cancer": null, "chronic_disease": "valve disease", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Presence", "of", "significant", "valve", "disease", "defined", "by", "the", "site", "cardiologist" ]
3,022
NCT03054519
,,,59:77:treatment
have an ABI > 0.90 with a 20% or higher drop in ABI after heel-rise exercise will be eligible
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "heel-rise exercise" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "have", "an", "ABI", ">", "0.90", "with", "a", "20%", "or", "higher", "drop", "in", "ABI", "after", "heel-rise", "exercise", "will", "be", "eligible" ]
3,655
NCT02533882
1:23:chronic_disease,
Cardiovascular disease event within the past six months
{ "allergy_name": null, "cancer": null, "chronic_disease": "Cardiovascular disease", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Cardiovascular", "disease", "event", "within", "the", "past", "six", "months" ]
2,648
NCT02242526
12:38:chronic_disease,92:104:chronic_disease,106:109:chronic_disease,111:126:chronic_disease
Absence of chronic medical conditions that will affect the quality of life survey, such as fibromyalgia, SLE, Crohn's disease, etc
{ "allergy_name": null, "cancer": null, "chronic_disease": "Crohn's disease", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Absence", "of", "chronic", "medical", "conditions", "that", "will", "affect", "the", "quality", "of", "life", "survey,", "such", "as", "fibromyalgia,", "SLE,", "Crohn's", "disease,", "etc" ]
6,593
NCT02465060
1:29:treatment
low molecular weight heparin is permitted for prophylactic or therapeutic use
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "low molecular weight heparin" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "low", "molecular", "weight", "heparin", "is", "permitted", "for", "prophylactic", "or", "therapeutic", "use" ]
4,381
NCT02843165
,,,82:101:treatment
Patient is a pregnant woman (pregnant women are excluded from this study because radiation treatment has known potential for teratogenic or abortifacient effects)
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "radiation treatment" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 0, 1, 0 ]
[ "Patient", "is", "a", "pregnant", "woman", "(pregnant", "women", "are", "excluded", "from", "this", "study", "because", "radiation", "treatment", "has", "known", "potential", "for", "teratogenic", "or", "abortifacient", "effects)" ]
2,115
NCT02640638
1:15:chronic_disease,,
Morbid Obesity with BMI >49.99
{ "allergy_name": null, "cancer": null, "chronic_disease": "Morbid Obesity", "treatment": null }
[ 0, 0, 0, 0, 0 ]
[ "Morbid", "Obesity", "with", "BMI", ">49.99" ]
4,049
NCT02343549
11:21:cancer
localized basal cell
{ "allergy_name": null, "cancer": "basal cell", "chronic_disease": null, "treatment": null }
[ 0, 0, 0 ]
[ "localized", "basal", "cell" ]
4,567
NCT02452268
1:4:chronic_disease
HIV positive patients
{ "allergy_name": null, "cancer": null, "chronic_disease": "HIV", "treatment": null }
[ 2, 0, 0 ]
[ "HIV", "positive", "patients" ]
120
NCT01951885
1:18:cancer
Hodgkin's disease
{ "allergy_name": null, "cancer": "Hodgkin's disease", "chronic_disease": null, "treatment": null }
[ 0, 0 ]
[ "Hodgkin's", "disease" ]
5,006
NCT02664909
12:22:chronic_disease
History of hemophilia
{ "allergy_name": null, "cancer": null, "chronic_disease": "hemophilia", "treatment": null }
[ 0, 0, 2 ]
[ "History", "of", "hemophilia" ]
4,033
NCT01898793
46:58:allergy_name
Known hypersensitivity to one or more of the study agents
{ "allergy_name": "study agents", "cancer": null, "chronic_disease": null, "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Known", "hypersensitivity", "to", "one", "or", "more", "of", "the", "study", "agents" ]
3,421
NCT03072381
68:74:treatment
self-reported failure of at least 2 of the most common treatments (NSAIDs, relative rest, ice, bracing) for CLE
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "NSAIDs" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
[ "self-reported", "failure", "of", "at", "least", "2", "of", "the", "most", "common", "treatments", "(NSAIDs,", "relative", "rest,", "ice,", "bracing)", "for", "CLE" ]
2,418
NCT00678145
5:13:chronic_disease
Non-diabetic individuals
{ "allergy_name": null, "cancer": null, "chronic_disease": "diabetic", "treatment": null }
[ 0, 0 ]
[ "Non-diabetic", "individuals" ]
2,225
NCT02019641
1:27:chronic_disease
Severe psychiatric disease
{ "allergy_name": null, "cancer": null, "chronic_disease": "Severe psychiatric disease", "treatment": null }
[ 0, 2, 0 ]
[ "Severe", "psychiatric", "disease" ]
4,945
NCT02169830
1:14:treatment,16:50:treatment,59:69:treatment
Nortriptyline: monoamine oxidase inhibitors (MAO) such as phenelzine
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "phenelzine" }
[ 0, 0, 0, 0, 0, 0, 0, 1 ]
[ "Nortriptyline:", "monoamine", "oxidase", "inhibitors", "(MAO)", "such", "as", "phenelzine" ]
6,674
NCT02598713
1:18:chronic_disease
Status asthmatics
{ "allergy_name": null, "cancer": null, "chronic_disease": "Status asthmatics", "treatment": null }
[ 0, 0 ]
[ "Status", "asthmatics" ]
4,083
NCT00788164
1:27:chronic_disease
Human papillomavirus (HPV) 16-positive disease by PCR
{ "allergy_name": null, "cancer": null, "chronic_disease": "Human papillomavirus (HPV)", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 1 ]
[ "Human", "papillomavirus", "(HPV)", "16-positive", "disease", "by", "PCR" ]
5,323
NCT02527265
35:41:chronic_disease,76:93:chronic_disease,109:120:treatment
History of physician diagnosis of asthma or any other clinically important pulmonary disease, or use of any medications to treat such conditions within the last year
{ "allergy_name": null, "cancer": null, "chronic_disease": "pulmonary disease", "treatment": "medications" }
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "History", "of", "physician", "diagnosis", "of", "asthma", "or", "any", "other", "clinically", "important", "pulmonary", "disease,", "or", "use", "of", "any", "medications", "to", "treat", "such", "conditions", "within", "the", "last", "year" ]
6,057
NCT02566928
39:43:chronic_disease
presents with signs and symptoms of a SSTI
{ "allergy_name": null, "cancer": null, "chronic_disease": "SSTI", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 2 ]
[ "presents", "with", "signs", "and", "symptoms", "of", "a", "SSTI" ]
4,161
NCT01983462
8:27:treatment,36:49:treatment,51:58:treatment,60:69:treatment,80:89:treatment,92:100:treatment
Taking thyroid medications such as levothyroxine (Levoxyl, Synthroid, Levoxyl, Unithroid); Levodopa
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "Levodopa" }
[ 0, 2, 1, 0, 0, 0, 0, 0, 0, 0, 1 ]
[ "Taking", "thyroid", "medications", "such", "as", "levothyroxine", "(Levoxyl,", "Synthroid,", "Levoxyl,", "Unithroid);", "Levodopa" ]
6,918
NCT02355002
46:51:treatment,
Use of other psychotropic medications (e.g., SSRIs) will be allowed provided the dose has been stable for > 12 weeks
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "SSRIs" }
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Use", "of", "other", "psychotropic", "medications", "(e.g.,", "SSRIs)", "will", "be", "allowed", "provided", "the", "dose", "has", "been", "stable", "for", ">", "12", "weeks" ]
4,547
NCT03016130
21:51:treatment,,
patients undergoing reduced intensity conditioning, only those regimens in which the expected neutropenia is ≥ 7 days are permitted and the patient must reside in the hospital
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "reduced intensity conditioning" }
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "patients", "undergoing", "reduced", "intensity", "conditioning,", "only", "those", "regimens", "in", "which", "the", "expected", "neutropenia", "is", "≥", "7", "days", "are", "permitted", "and", "the", "patient", "must", "reside", "in", "the", "hospital" ]
3,707
NCT02589340
1:20:chronic_disease
Parkinson's disease diagnosis
{ "allergy_name": null, "cancer": null, "chronic_disease": "Parkinson's disease", "treatment": null }
[ 2, 0, 0 ]
[ "Parkinson's", "disease", "diagnosis" ]
1,931
NCT01239160
21:111:cancer
have a diagnosis of primary or secondary late Stage 2 or 3 unilateral or bilateral lower extremity lymphoedema
{ "allergy_name": null, "cancer": "primary or secondary late Stage 2 or 3 unilateral or bilateral lower extremity lymphoedema", "chronic_disease": null, "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "have", "a", "diagnosis", "of", "primary", "or", "secondary", "late", "Stage", "2", "or", "3", "unilateral", "or", "bilateral", "lower", "extremity", "lymphoedema" ]
5,274
NCT00980538
50:62:chronic_disease,64:83:chronic_disease,238:247:treatment,253:256:treatment
Any active clinically significant disease (e.g., pancreatitis, cardiac dysfunction) or findings of medical history, laboratory or physical examination that, in the investigator's opinion, would compromise the participant's safety during treatment with ETR
{ "allergy_name": null, "cancer": null, "chronic_disease": "cardiac dysfunction", "treatment": "ETR" }
[ 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1 ]
[ "Any", "active", "clinically", "significant", "disease", "(e.g.,", "pancreatitis,", "cardiac", "dysfunction)", "or", "findings", "of", "medical", "history,", "laboratory", "or", "physical", "examination", "that,", "in", "the", "investigator's", "opinion,", "would", "c...
7,285
NCT03121586
59:70:chronic_disease,72:82:chronic_disease,84:98:chronic_disease,100:111:chronic_disease,113:129:chronic_disease,131:136:chronic_disease,138:145:chronic_disease,147:158:chronic_disease,169:185:chronic_disease,197:203:cancer,207:219:cancer
Patient has current evidence of a serious and/or unstable psychiatric, neurologic, cardiovascular, respiratory, gastrointestinal, renal, hepatic, hematologic, or other medical disorder, including cancer or malignancies, which would affect the patient's ability to participate in the program
{ "allergy_name": null, "cancer": "malignancies", "chronic_disease": "medical disorder", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Patient", "has", "current", "evidence", "of", "a", "serious", "and/or", "unstable", "psychiatric,", "neurologic,", "cardiovascular,", "respiratory,", "gastrointestinal,", "renal,", "hepatic,", "hematologic,", "or", "other", "medical", "disorder,", "including", "cancer", ...
5,561
NCT02423863
,,,,128:143:treatment
Transaminases ≤ 2 times above the upper limits of the institutional normal, - INR<2 (international normalized ratio) if off of anticoagulation
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "anticoagulation" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4 ]
[ "Transaminases", "≤", "2", "times", "above", "the", "upper", "limits", "of", "the", "institutional", "normal,", "-", "INR<2", "(international", "normalized", "ratio)", "if", "off", "of", "anticoagulation" ]
2,163
NCT03065465
32:44:chronic_disease
Presence of a benign appearing peptic ulcer
{ "allergy_name": null, "cancer": null, "chronic_disease": "peptic ulcer", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 2 ]
[ "Presence", "of", "a", "benign", "appearing", "peptic", "ulcer" ]
2,760
NCT02553265
24:26:chronic_disease
Confirmed diagnosis of FD (genetic testing)
{ "allergy_name": null, "cancer": null, "chronic_disease": "FD", "treatment": null }
[ 0, 0, 0, 2, 0, 0 ]
[ "Confirmed", "diagnosis", "of", "FD", "(genetic", "testing)" ]
4,200
NCT01422005
26:43:chronic_disease
Subjects must have had a unilateral stroke
{ "allergy_name": null, "cancer": null, "chronic_disease": "unilateral stroke", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 2 ]
[ "Subjects", "must", "have", "had", "a", "unilateral", "stroke" ]
5,245
NCT02347891
,,,,,,78:86:chronic_disease,,,,,,,,,,
Presence of positive autoantibody (ANA >1:80 or RNP or SSA/SSB or any of the myositis specific autoantibody: antisynthetase autoantibodies (anti-Jo-1, PL-7, PL-12, EJ, OJ, KS), anti-SRP, anti-Mi-2, anti-p140)
{ "allergy_name": null, "cancer": null, "chronic_disease": "myositis", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Presence", "of", "positive", "autoantibody", "(ANA", ">1:80", "or", "RNP", "or", "SSA/SSB", "or", "any", "of", "the", "myositis", "specific", "autoantibody:", "antisynthetase", "autoantibodies", "(anti-Jo-1,", "PL-7,", "PL-12,", "EJ,", "OJ,", "KS),", "anti-SRP,", ...
2,922
NCT02911831
21:48:chronic_disease,65:80:chronic_disease,92:114:chronic_disease,118:136:chronic_disease
Patients with known bleeding/clotting disorders or a history of thromboembolism (including deep venous thrombosis or pulmonary embolism)
{ "allergy_name": null, "cancer": null, "chronic_disease": "pulmonary embolism", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 2, 0 ]
[ "Patients", "with", "known", "bleeding/clotting", "disorders", "or", "a", "history", "of", "thromboembolism", "(including", "deep", "venous", "thrombosis", "or", "pulmonary", "embolism)" ]
5,734
NCT02101736
,,,98:107:treatment
Hemoptysis of ≥0.5 teaspoon (2.5 mL) of red blood within 3 months before the first dose of study treatment
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "treatment" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
[ "Hemoptysis", "of", "≥0.5", "teaspoon", "(2.5", "mL)", "of", "red", "blood", "within", "3", "months", "before", "the", "first", "dose", "of", "study", "treatment" ]
1,150
NCT03137771
20:36:treatment,38:68:treatment,74:79:cancer
Patients receiving targeted therapy (non-cytotoxic systemic therapy) for NSCLC in the first-line setting
{ "allergy_name": null, "cancer": "NSCLC", "chronic_disease": null, "treatment": "non-cytotoxic systemic therapy" }
[ 0, 0, 0, 1, 0, 0, 0, 0, 3, 0, 0, 0, 0 ]
[ "Patients", "receiving", "targeted", "therapy", "(non-cytotoxic", "systemic", "therapy)", "for", "NSCLC", "in", "the", "first-line", "setting" ]
5,543
NCT00788164
1:16:treatment,21:27:treatment,38:80:chronic_disease
Colposcopically and biopsy confirmed grade 3 cervical intraepithelial neoplasia
{ "allergy_name": null, "cancer": null, "chronic_disease": "grade 3 cervical intraepithelial neoplasia", "treatment": "biopsy" }
[ 0, 0, 1, 0, 0, 0, 0, 0, 2 ]
[ "Colposcopically", "and", "biopsy", "confirmed", "grade", "3", "cervical", "intraepithelial", "neoplasia" ]
7,314
NCT01568918
1:19:treatment
Lumbar Laminectomy
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "Lumbar Laminectomy" }
[ 0, 0 ]
[ "Lumbar", "Laminectomy" ]
5,199
NCT02584309
1:31:cancer
Malignant fibrous histiocytoma
{ "allergy_name": null, "cancer": "Malignant fibrous histiocytoma", "chronic_disease": null, "treatment": null }
[ 0, 0, 0 ]
[ "Malignant", "fibrous", "histiocytoma" ]
4,114
NCT02415660
16:33:chronic_disease,43:70:treatment,75:78:treatment,110:122:chronic_disease,124:142:chronic_disease,146:170:treatment
History of any systemic disorder in which thoracic spine manipulation and TDN would be contraindicated (i.e. osteoporosis, bleeding disorders or anticoagulant medication use)
{ "allergy_name": null, "cancer": null, "chronic_disease": "bleeding disorders", "treatment": "anticoagulant medication" }
[ 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0 ]
[ "History", "of", "any", "systemic", "disorder", "in", "which", "thoracic", "spine", "manipulation", "and", "TDN", "would", "be", "contraindicated", "(i.e.", "osteoporosis,", "bleeding", "disorders", "or", "anticoagulant", "medication", "use)" ]
6,319
NCT03050801
13:55:chronic_disease,85:91:chronic_disease,93:110:chronic_disease,112:129:chronic_disease,131:144:chronic_disease,148:164:chronic_disease
Any current major neurological or psychiatric disorder such as (but not limited to) stroke, Parkinson disease, Alzheimer disease, schizophrenia or major depression
{ "allergy_name": null, "cancer": null, "chronic_disease": "major depression", "treatment": null }
[ 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 2 ]
[ "Any", "current", "major", "neurological", "or", "psychiatric", "disorder", "such", "as", "(but", "not", "limited", "to)", "stroke,", "Parkinson", "disease,", "Alzheimer", "disease,", "schizophrenia", "or", "major", "depression" ]
5,626
NCT02741180
18:40:chronic_disease
History of prior cardiovascular disease or significant risk factors
{ "allergy_name": null, "cancer": null, "chronic_disease": "cardiovascular disease", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "History", "of", "prior", "cardiovascular", "disease", "or", "significant", "risk", "factors" ]
1,540
NCT02533674
1:18:cancer
Urothelial cancer
{ "allergy_name": null, "cancer": "Urothelial cancer", "chronic_disease": null, "treatment": null }
[ 0, 3 ]
[ "Urothelial", "cancer" ]
4,234
NCT03104725
10:43:treatment
Taking a monoamine oxidase (MAO) inhibitor
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "monoamine oxidase (MAO) inhibitor" }
[ 0, 0, 0, 0, 0, 0 ]
[ "Taking", "a", "monoamine", "oxidase", "(MAO)", "inhibitor" ]
3,585
NCT01880567
14:26:chronic_disease,41:58:chronic_disease,67:102:chronic_disease,104:120:chronic_disease,131:140:treatment,146:166:treatment,168:177:treatment,181:198:treatment,200:217:chronic_disease,222:241:chronic_disease
uncontrolled hypertension, uncontrolled diabetes mellitus, active/symptomatic coronary artery disease, active infection requiring treatment with systemic antibiotics, antiviral or antifungal agents, active hemorrhage, or psychiatric illness
{ "allergy_name": null, "cancer": null, "chronic_disease": "psychiatric illness", "treatment": "antifungal agents" }
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 2, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
[ "uncontrolled", "hypertension,", "uncontrolled", "diabetes", "mellitus,", "active/symptomatic", "coronary", "artery", "disease,", "active", "infection", "requiring", "treatment", "with", "systemic", "antibiotics,", "antiviral", "or", "antifungal", "agents,", "active", "hemo...
7,013
NCT02140255
15:19:treatment,
No receipt of ARVs during the current pregnancy
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "ARVs" }
[ 0, 0, 0, 1, 0, 0, 0, 0 ]
[ "No", "receipt", "of", "ARVs", "during", "the", "current", "pregnancy" ]
2,951
NCT02451423
82:90:allergy_name,94:114:allergy_name,118:133:allergy_name
History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins
{ "allergy_name": "fusion proteins", "cancer": null, "chronic_disease": null, "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "History", "of", "severe", "allergic,", "anaphylactic,", "or", "other", "hypersensitivity", "reactions", "to", "chimeric", "or", "humanized", "antibodies", "or", "fusion", "proteins" ]
5,472
NCT02421380
10:34:chronic_disease
unstable cardiovascular condition
{ "allergy_name": null, "cancer": null, "chronic_disease": "cardiovascular condition", "treatment": null }
[ 0, 0, 0 ]
[ "unstable", "cardiovascular", "condition" ]
4,445
NCT02837510
1:20:treatment
Anti-anxiety agents
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "Anti-anxiety agents" }
[ 0, 0 ]
[ "Anti-anxiety", "agents" ]
3,897
NCT02312518
,,88:97:treatment
Greater than 30% reduction in wound size during the first two weeks of observation and treatment by the investigator
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "treatment" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
[ "Greater", "than", "30%", "reduction", "in", "wound", "size", "during", "the", "first", "two", "weeks", "of", "observation", "and", "treatment", "by", "the", "investigator" ]
1,090
NCT02286687
,36:45:treatment,36:152:treatment,112:120:treatment,122:132:treatment,137:152:treatment,
Patients must be >= 4 weeks beyond treatment with any chemotherapy or other investigational therapy to include hormonal, biological, or targeted agents; or at least 5 half-lives from hormonal, biological, or targeted agents, whichever is shorter at the time of treatment initiation
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "targeted agents" }
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
[ "Patients", "must", "be", ">=", "4", "weeks", "beyond", "treatment", "with", "any", "chemotherapy", "or", "other", "investigational", "therapy", "to", "include", "hormonal,", "biological,", "or", "targeted", "agents;", "or", "at", "least", "5", "half-lives", "fr...
6,536
NCT03129542
1:24:treatment
Fludrocortisone acetate is a current home medication
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "Fludrocortisone acetate" }
[ 0, 0, 0, 0, 0, 0, 1 ]
[ "Fludrocortisone", "acetate", "is", "a", "current", "home", "medication" ]
3,550
NCT02152995
20:23:chronic_disease,28:31:chronic_disease,32:41:chronic_disease
chronic or cleared HBV and HCV infection
{ "allergy_name": null, "cancer": null, "chronic_disease": "infection", "treatment": null }
[ 0, 0, 0, 0, 0, 2, 2 ]
[ "chronic", "or", "cleared", "HBV", "and", "HCV", "infection" ]
6,697
NCT01312857
23:38:treatment,39:55:treatment,102:111:treatment
Patients who have had prior anti EGFR antibody therapy inhibitors and who have not responded to this treatment will be excluded
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "treatment" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
[ "Patients", "who", "have", "had", "prior", "anti", "EGFR", "antibody", "therapy", "inhibitors", "and", "who", "have", "not", "responded", "to", "this", "treatment", "will", "be", "excluded" ]
7,246
NCT01742182
13:23:chronic_disease,,
Presence of depression defined as the Beck Depression Inventory (BDI) score >14
{ "allergy_name": null, "cancer": null, "chronic_disease": "depression", "treatment": null }
[ 0, 0, 2, 0, 0, 0, 0, 2, 0, 0, 0, 0 ]
[ "Presence", "of", "depression", "defined", "as", "the", "Beck", "Depression", "Inventory", "(BDI)", "score", ">14" ]
1,500
NCT02393794
1:20:treatment,22:57:treatment,59:68:treatment,72:84:treatment
herapy with heparin, low molecular weight heparin (LMWH), Factor Xa or fondaparinux is allowed
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "fondaparinux" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
[ "herapy", "with", "heparin,", "low", "molecular", "weight", "heparin", "(LMWH),", "Factor", "Xa", "or", "fondaparinux", "is", "allowed" ]
6,364
NCT02932410
,41:64:treatment
Subjects receiving a combination of > 2 PAH-specific treatments at randomization
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "PAH-specific treatments" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1 ]
[ "Subjects", "receiving", "a", "combination", "of", ">", "2", "PAH-specific", "treatments", "at", "randomization" ]
3,791
NCT02926248
20:33:treatment
Patients requiring bilateral MUA
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "bilateral MUA" }
[ 0, 0, 0, 0 ]
[ "Patients", "requiring", "bilateral", "MUA" ]
3,804
NCT02568267
7:32:chronic_disease,47:55:chronic_disease,105:116:chronic_disease
Known interstitial lung disease, interstitial fibrosis, or history of tyrosine kinase inhibitor-induced pneumonitis
{ "allergy_name": null, "cancer": null, "chronic_disease": "pneumonitis", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
[ "Known", "interstitial", "lung", "disease,", "interstitial", "fibrosis,", "or", "history", "of", "tyrosine", "kinase", "inhibitor-induced", "pneumonitis" ]
5,956
NCT02908841
,40:52:treatment
Women scheduled for standard multiport laparoscopic
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "laparoscopic" }
[ 0, 0, 0, 0, 0, 1 ]
[ "Women", "scheduled", "for", "standard", "multiport", "laparoscopic" ]
3,101
NCT02592707
22:36:cancer,102:147:cancer,152:175:cancer
unresectable typical lung carcinoid or atypical lung carcinoid are acceptable (with the exception of Large Cell Bronchial Neuroendocrine Neoplasms and Small Cell Lung Cancers) (Caplin 2015)
{ "allergy_name": null, "cancer": "Small Cell Lung Cancers", "chronic_disease": null, "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "unresectable", "typical", "lung", "carcinoid", "or", "atypical", "lung", "carcinoid", "are", "acceptable", "(with", "the", "exception", "of", "Large", "Cell", "Bronchial", "Neuroendocrine", "Neoplasms", "and", "Small", "Cell", "Lung", "Cancers)", "(Caplin", "2015)"...
5,882
NCT02146924
30:43:treatment
he/she must have appropriate venous access
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "venous access" }
[ 0, 0, 0, 0, 0, 0 ]
[ "he/she", "must", "have", "appropriate", "venous", "access" ]
3,387
NCT03006770
8:18:cancer
Active malignancy
{ "allergy_name": null, "cancer": "malignancy", "chronic_disease": null, "treatment": null }
[ 0, 2 ]
[ "Active", "malignancy" ]
413
NCT02122081
31:65:chronic_disease
Patients seropositive for the human immunodeficiency virus (HIV)
{ "allergy_name": null, "cancer": null, "chronic_disease": "human immunodeficiency virus (HIV)", "treatment": null }
[ 0, 0, 0, 0, 0, 2, 0, 0 ]
[ "Patients", "seropositive", "for", "the", "human", "immunodeficiency", "virus", "(HIV)" ]
1,391
NCT02416206
,43:55:treatment
Within 9 months of the start of induction chemotherapy and no evidence of relapse or progression
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "chemotherapy" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
[ "Within", "9", "months", "of", "the", "start", "of", "induction", "chemotherapy", "and", "no", "evidence", "of", "relapse", "or", "progression" ]
867
NCT02254863
14:23:chronic_disease,25:30:chronic_disease,35:51:chronic_disease,67:89:treatment
Uncontrolled bacterial, viral, or fungal infection at the time of pre-UCBT cytoreduction
{ "allergy_name": null, "cancer": null, "chronic_disease": "fungal infection", "treatment": "pre-UCBT cytoreduction" }
[ 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0 ]
[ "Uncontrolled", "bacterial,", "viral,", "or", "fungal", "infection", "at", "the", "time", "of", "pre-UCBT", "cytoreduction" ]
6,581
NCT02423772
65:78:chronic_disease,80:99:chronic_disease,101:110:chronic_disease,114:136:chronic_disease
Meet diagnostic criteria for a current or past DSM diagnosis of schizophrenia, delusional disorder, psychotic or dissociative disorders
{ "allergy_name": null, "cancer": null, "chronic_disease": "dissociative disorders", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0 ]
[ "Meet", "diagnostic", "criteria", "for", "a", "current", "or", "past", "DSM", "diagnosis", "of", "schizophrenia,", "delusional", "disorder,", "psychotic", "or", "dissociative", "disorders" ]
6,308
NCT00967577
18:21:chronic_disease
Known history of HIV
{ "allergy_name": null, "cancer": null, "chronic_disease": "HIV", "treatment": null }
[ 0, 0, 0, 2 ]
[ "Known", "history", "of", "HIV" ]
219
NCT01538966
23:35:cancer
The patient harbors a macroadenoma with visual field defects due to chiasmatic compression
{ "allergy_name": null, "cancer": "macroadenoma", "chronic_disease": null, "treatment": null }
[ 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "The", "patient", "harbors", "a", "macroadenoma", "with", "visual", "field", "defects", "due", "to", "chiasmatic", "compression" ]
5,212
NCT02592551
28:46:chronic_disease,
Active or prior documented autoimmune disease within the past 2 years
{ "allergy_name": null, "cancer": null, "chronic_disease": "autoimmune disease", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Active", "or", "prior", "documented", "autoimmune", "disease", "within", "the", "past", "2", "years" ]
1,458
NCT01582191
32:42:allergy_name,44:51:allergy_name,53:68:allergy_name,77:105:allergy_name
History of hypersensitivity to vandetanib, lactose, murine products, or any component of the formulation
{ "allergy_name": "component of the formulation", "cancer": null, "chronic_disease": null, "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "History", "of", "hypersensitivity", "to", "vandetanib,", "lactose,", "murine", "products,", "or", "any", "component", "of", "the", "formulation" ]
7,167
NCT02187848
1:32:treatment
Prior therapy targeting CEACAM5
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "Prior therapy targeting CEACAM5" }
[ 0, 1, 0, 0 ]
[ "Prior", "therapy", "targeting", "CEACAM5" ]
4,750
NCT02466126
13:20:chronic_disease,22:31:chronic_disease,35:60:chronic_disease
presence of bipolar, psychotic or substance-abuse disorders
{ "allergy_name": null, "cancer": null, "chronic_disease": "substance-abuse disorders", "treatment": null }
[ 0, 0, 0, 2, 0, 0, 0 ]
[ "presence", "of", "bipolar,", "psychotic", "or", "substance-abuse", "disorders" ]
6,224
NCT01174108
,,110:114:treatment
ECOG performance status of 3 or more (See Bone & Marrow Transplant Consortium Supportive Care Guidelines for HSCT Recipients)
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "HSCT" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0 ]
[ "ECOG", "performance", "status", "of", "3", "or", "more", "(See", "Bone", "&", "Marrow", "Transplant", "Consortium", "Supportive", "Care", "Guidelines", "for", "HSCT", "Recipients)" ]
2,328
NCT02496208
1:16:treatment,22:33:treatment,26:33:treatment,176:196:cancer
Prior treatment with any therapy on the programmed cell death 1 (PD-1)/PD-L1 axis or anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) inhibitors unless enrolling the urothelial carcinoma with previous checkpoint inhibition therapy expansion cohort
{ "allergy_name": null, "cancer": "urothelial carcinoma", "chronic_disease": null, "treatment": "therapy" }
[ 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 1, 0, 0 ]
[ "Prior", "treatment", "with", "any", "therapy", "on", "the", "programmed", "cell", "death", "1", "(PD-1)/PD-L1", "axis", "or", "anti-cytotoxic", "T-lymphocyte-associated", "protein", "4", "(CTLA-4)", "inhibitors", "unless", "enrolling", "the", "urothelial", "carcinoma...
6,169
NCT02158793
19:37:chronic_disease,51:79:chronic_disease,91:121:chronic_disease
Subjects with any cognitive deficits related to a TBI (traumatic brain injury) and or any organic neurological disorders will not be considered for this protocol
{ "allergy_name": null, "cancer": null, "chronic_disease": "organic neurological disorders", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Subjects", "with", "any", "cognitive", "deficits", "related", "to", "a", "TBI", "(traumatic", "brain", "injury)", "and", "or", "any", "organic", "neurological", "disorders", "will", "not", "be", "considered", "for", "this", "protocol" ]
6,693
NCT02004275
,,,,199:211:treatment
Must have a negative serum or urine pregnancy test with a sensitivity of at least 25 mlU/ml no more than 14 days prior to registration and must agree to repeat this test within 24 hours of starting pomalidomide
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "pomalidomide" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
[ "Must", "have", "a", "negative", "serum", "or", "urine", "pregnancy", "test", "with", "a", "sensitivity", "of", "at", "least", "25", "mlU/ml", "no", "more", "than", "14", "days", "prior", "to", "registration", "and", "must", "agree", "to", "repeat", "this"...
2,291
NCT03159936
1:17:treatment,
Systemic therapy is allowed if on a stable dose and using for at least 3 months -background therapies outlined in Protocol
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "Systemic therapy" }
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
[ "Systemic", "therapy", "is", "allowed", "if", "on", "a", "stable", "dose", "and", "using", "for", "at", "least", "3", "months", "-background", "therapies", "outlined", "in", "Protocol" ]
3,513
NCT02520791
43:61:chronic_disease
Patients with active, known, or suspected autoimmune disease
{ "allergy_name": null, "cancer": null, "chronic_disease": "autoimmune disease", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Patients", "with", "active,", "known,", "or", "suspected", "autoimmune", "disease" ]
1,461
NCT01434316
7:19:treatment
Prior chemotherapy
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "chemotherapy" }
[ 0, 1 ]
[ "Prior", "chemotherapy" ]
381
NCT02140255
24:28:treatment,
Mother did not receive ARVs during the current pregnancy per criteria above
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "ARVs" }
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
[ "Mother", "did", "not", "receive", "ARVs", "during", "the", "current", "pregnancy", "per", "criteria", "above" ]
2,950
NCT00929006
39:49:treatment
Restrictions on use of other drugs or treatments
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "treatments" }
[ 0, 0, 0, 0, 0, 0, 0, 1 ]
[ "Restrictions", "on", "use", "of", "other", "drugs", "or", "treatments" ]
1,967
NCT03096418
33:68:treatment
Patients must be candidates for neoadjuvant paclitaxel chemotherapy by their treating oncologist
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "neoadjuvant paclitaxel chemotherapy" }
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0 ]
[ "Patients", "must", "be", "candidates", "for", "neoadjuvant", "paclitaxel", "chemotherapy", "by", "their", "treating", "oncologist" ]
3,597
NCT03113825
1:27:treatment,31:41:treatment,44:48:treatment,52:56:treatment,64:74:treatment
Primary surgical treatment is lumpectomy + SLNB or ALND --or-- mastectomy + ALND
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "mastectomy" }
[ 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0 ]
[ "Primary", "surgical", "treatment", "is", "lumpectomy", "+", "SLNB", "or", "ALND", "--or--", "mastectomy", "+", "ALND" ]
5,568
NCT01787409
30:55:treatment
Capable of swallowing intact study medication capsules
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "study medication capsules" }
[ 0, 0, 0, 0, 0, 1, 0 ]
[ "Capable", "of", "swallowing", "intact", "study", "medication", "capsules" ]
5,099
NCT02508038
10:14:chronic_disease,26:30:chronic_disease,42:45:chronic_disease
MPX for: HepB (HBV-PCR), HepC (HCV-PCR), HIV (HIV-PCR)
{ "allergy_name": null, "cancer": null, "chronic_disease": "HIV", "treatment": null }
[ 0, 0, 0, 0, 2, 0, 2, 0 ]
[ "MPX", "for:", "HepB", "(HBV-PCR),", "HepC", "(HCV-PCR),", "HIV", "(HIV-PCR)" ]
6,126
NCT02564744
122:130:cancer
Participants must have evaluable or measurable disease in accordance with the International Working Group Guidelines for Lymphoma
{ "allergy_name": null, "cancer": "Lymphoma", "chronic_disease": null, "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3 ]
[ "Participants", "must", "have", "evaluable", "or", "measurable", "disease", "in", "accordance", "with", "the", "International", "Working", "Group", "Guidelines", "for", "Lymphoma" ]
2,659
NCT01037790
74:87:treatment,
The subject has not recovered from clinically-meaningful toxicity due to prior therapy (i.e., back to baseline or Grade ≤ 1)
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "prior therapy" }
[ 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "The", "subject", "has", "not", "recovered", "from", "clinically-meaningful", "toxicity", "due", "to", "prior", "therapy", "(i.e.,", "back", "to", "baseline", "or", "Grade", "≤", "1)" ]
38
NCT02058095
34:58:chronic_disease
no clinical signs or symptoms of congestive heart failure
{ "allergy_name": null, "cancer": null, "chronic_disease": "congestive heart failure", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "no", "clinical", "signs", "or", "symptoms", "of", "congestive", "heart", "failure" ]
813
NCT02838797
16:40:treatment,81:92:treatment,102:113:treatment,115:131:treatment,136:169:treatment,174:193:chronic_disease
history of any gastrointestinal surgery that might impact drug absorption (e.g. gastrectomy), use of apomorphine, anticholinergics, or carbidopa/levodopa intestinal gel for Parkinson's Disease
{ "allergy_name": null, "cancer": null, "chronic_disease": "Parkinson's Disease", "treatment": "carbidopa/levodopa intestinal gel" }
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0 ]
[ "history", "of", "any", "gastrointestinal", "surgery", "that", "might", "impact", "drug", "absorption", "(e.g.", "gastrectomy),", "use", "of", "apomorphine,", "anticholinergics,", "or", "carbidopa/levodopa", "intestinal", "gel", "for", "Parkinson's", "Disease" ]
5,770
NCT02367196
1:21:cancer,23:31:cancer,35:48:cancer,51:71:cancer
High grade lymphomas (Burkitts or lymphoblastic), plasma cell leukemia
{ "allergy_name": null, "cancer": "plasma cell leukemia", "chronic_disease": null, "treatment": null }
[ 0, 0, 3, 0, 0, 0, 0, 0, 3 ]
[ "High", "grade", "lymphomas", "(Burkitts", "or", "lymphoblastic),", "plasma", "cell", "leukemia" ]
6,401
NCT02278315
1:16:treatment,40:60:treatment,65:80:treatment
Prior treatment with or intolerance to proteasome inhibitor and immunomodulator
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "immunomodulator" }
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 1 ]
[ "Prior", "treatment", "with", "or", "intolerance", "to", "proteasome", "inhibitor", "and", "immunomodulator" ]
6,540
NCT02581215
29:38:treatment
Known allergy to any of the treatment components
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "treatment" }
[ 0, 0, 0, 0, 0, 0, 1, 0 ]
[ "Known", "allergy", "to", "any", "of", "the", "treatment", "components" ]
963
NCT02287558
,,,,,,205:217:treatment,,,
Females of childbearing potential (FCBP)† must have a negative serum or urine pregnancy test with a sensitivity of at least 25 mIU/mL within 10 - 14 days prior to and again within 24 hours of prescribing pomalidomide and must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable me...
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "pomalidomide" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0...
[ "Females", "of", "childbearing", "potential", "(FCBP)†", "must", "have", "a", "negative", "serum", "or", "urine", "pregnancy", "test", "with", "a", "sensitivity", "of", "at", "least", "25", "mIU/mL", "within", "10", "-", "14", "days", "prior", "to", "and", ...
2,289
NCT02424968
,,157:167:cancer
diagnosed > 5 years ago without evidence of disease, OR treated =< 5 years ago but have a greater than 50% chance of life expectancy of >= 5 years for that malignancy
{ "allergy_name": null, "cancer": "malignancy", "chronic_disease": null, "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
[ "diagnosed", ">", "5", "years", "ago", "without", "evidence", "of", "disease,", "OR", "treated", "=<", "5", "years", "ago", "but", "have", "a", "greater", "than", "50%", "chance", "of", "life", "expectancy", "of", ">=", "5", "years", "for", "that", "mali...
472
NCT02746458
,173:192:treatment
Additional fracture, dislocations or soft tissue injuries to the study limb that would compromise the ability to weight bear as tolerated and initiate PT within 28 days of definitive fixation
{ "allergy_name": null, "cancer": null, "chronic_disease": null, "treatment": "definitive fixation" }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Additional", "fracture,", "dislocations", "or", "soft", "tissue", "injuries", "to", "the", "study", "limb", "that", "would", "compromise", "the", "ability", "to", "weight", "bear", "as", "tolerated", "and", "initiate", "PT", "within", "28", "days", "of", "def...
3,152
NCT02912572
8:26:chronic_disease
Active autoimmune disease that might deteriorate when receiving an immunostimulatory agent
{ "allergy_name": null, "cancer": null, "chronic_disease": "autoimmune disease", "treatment": null }
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
[ "Active", "autoimmune", "disease", "that", "might", "deteriorate", "when", "receiving", "an", "immunostimulatory", "agent" ]
1,449
NCT03179449
27:38:allergy_name
Known hypersensitivity to ferumoxytol or any of its components
{ "allergy_name": "ferumoxytol", "cancer": null, "chronic_disease": null, "treatment": null }
[ 0, 0, 0, 4, 0, 0, 0, 0, 0 ]
[ "Known", "hypersensitivity", "to", "ferumoxytol", "or", "any", "of", "its", "components" ]
2,527